Drivers of biodiagnostic development.
The promise of point-of-care medical diagnostics - tests that can be carried out at the site of patient care - is enormous, bringing the benefits of fast and reliable testing and allowing rapid decisions on the course of treatment to be made. To this end, much innovation is occurring in technologies for use in biodiagnostic tests. Assays based on nanomaterials, for example, are now beginning to make the transition from the laboratory to the clinic. But the potential for such assays to become part of routine medical testing depends on many scientific factors, including sensitivity, selectivity and versatility, as well as technological, financial and policy factors.
Giljohann
David A
DA
Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.
Mirkin
Chad A
CA
D003955:Diagnostic Tests, Routine / Q000295:instrumentation* / Q000379:methods* / Q000639:trends; D006801:Humans; D050997:Nanomedicine / Q000295:instrumentation / Q000379:methods; D019095:Point-of-Care Systems / Q000639:trends; D012680:Sensitivity and Specificity